I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 22% ± 8% | |
| CD8-positive, alpha-beta T cell | 6 studies | 19% ± 2% | |
| plasmacytoid dendritic cell | 6 studies | 25% ± 8% | |
| basal cell | 5 studies | 30% ± 15% | |
| CD4-positive, alpha-beta T cell | 5 studies | 19% ± 2% | |
| astrocyte | 5 studies | 26% ± 4% | |
| oligodendrocyte | 5 studies | 20% ± 3% | |
| epithelial cell | 4 studies | 35% ± 9% | |
| regulatory T cell | 4 studies | 18% ± 2% | |
| type I pneumocyte | 4 studies | 16% ± 1% | |
| GABAergic neuron | 4 studies | 27% ± 6% | |
| glutamatergic neuron | 4 studies | 33% ± 5% | |
| oligodendrocyte precursor cell | 4 studies | 21% ± 4% | |
| hematopoietic precursor cell | 3 studies | 23% ± 6% | |
| pro-B cell | 3 studies | 26% ± 5% | |
| retinal rod cell | 3 studies | 17% ± 2% | |
| ciliated cell | 3 studies | 23% ± 4% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 17% ± 2% | |
| fibroblast | 3 studies | 17% ± 2% | |
| dendritic cell | 3 studies | 25% ± 5% | |
| transit amplifying cell | 3 studies | 34% ± 20% | |
| goblet cell | 3 studies | 20% ± 4% | |
| mesothelial cell | 3 studies | 26% ± 14% | |
| neuron | 3 studies | 25% ± 2% | |
| natural killer cell | 3 studies | 26% ± 9% |
